At the news
? NEUTRALIMPACT 4/10 6-K filed Apr 24, 2026 at 06:25 ET
Dr. Reddy's Laboratories confirmed it has not yet received Health Canada approval for its Semaglutide Injection, though it has obtained Drug Identification Numbers (DINs). The company remains engaged with regulators and plans to launch the product upon approval. No additional material information requiring disclosure was reported.
- Company has not yet received Health Canada approval (Notice of Compliance) for Semaglutide Injection.
- Drug Identification Numbers (DINs) for Semaglutide Injection were received on April 22, 2026.
- Filing is in response to a media report and confirms limited regulatory progress without new financial or clinical data.
- No material event or information beyond this update requires disclosure under SEBI rules.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access